Library

Rasagilin

Rasagiline irreversibly acylates the flavin site of MAO-B, giving approximately 90% inhibition at 1 mg/day within 1-2 weeks. Although its plasma half-life is approximately 3 h, functional recovery depends on MAO-B resynthesis (approximately 40 days), so a single 1 mg dose can keep tyramine thresholds lower for several days. Selectivity diminishes above 2 mg/day, raising dietary and pressor risk comparable to classical non-selective MAOIs. Case surveys and pharmacovigilance reviews document serotonin-syndrome clusters when rasagiline is combined with SSRIs or MDMA-like agents—even at therapeutic doses. Bluelight users typically employ 0.5-1 mg to amplify phenethylamine or stimulant effects, reporting brighter mood, clearer focus, and longer stimulant plateau, but also warn that >2 mg 'feels wired' and makes tyramine flushes more likely.

Rasagilin molecular structure
Rasagilin molecular structure diagram from the DrugsPRO substance library.

Also known as: Azilect, Tvp-1012, Agn-1135

Classification

  • Chemical: Aminoindane
  • Chemical: Medicine
  • Tag: MAO-B-inhibitor
  • Tag: Not psychoactive
  • Tag: Pharmaceutical
  • Tag: Propargylamine

Effects

  • Reduced Fatigue
  • Slight Appetite Suppression
  • Occasional Insomnia
  • Subtle Mental Alertness
  • Enhanced Motivation
  • Mild Euphoria
  • Vivid Dreams

Routes of Administration

Oral (Tablet; Sublingually Dissolved)

Dosage

  • Threshold: 0.25 mg
  • Light: 0.25-0.5 mg
  • Common: 0.5-1 mg
  • Strong: 1-2 mg
  • Heavy: 2 mg

Duration

  • Onset: 0.5-1 h
  • Peak: 1-2 h
  • Offset: 12-24 h
  • After Effects: 12 h

Oral (Powder / Capsule)

Dosage

  • Threshold: 0.25 mg
  • Light: 0.25-0.5 mg
  • Common: 0.5-1 mg
  • Strong: 1-2 mg
  • Heavy: 2 mg

Duration

  • Onset: 0.5-1 h
  • Peak: 1-2 h
  • Offset: 12-24 h
  • After Effects: 12 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Rasagiline - Treoir substaint DrugsPRO

Rasagiline: Rasagiline irreversibly acylates the flavin site of MAO-B, giving approximately 90% inhibition at 1 mg/day within 1-2 weeks. Although its plasma half-life is approximately 3 h, functional recovery depends on MAO-B resynthesis (approximately 40 days), so a single 1 mg dose can keep tyrami

Related pages